4.8 Article

In-Plane Parallel Scanning: A Microarray Technology for Point-of-Care Testing

Journal

ANALYTICAL CHEMISTRY
Volume 82, Issue 21, Pages 8856-8865

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ac101571b

Keywords

-

Funding

  1. PLC Diagnostics, Inc.
  2. University of Utah

Ask authors/readers for more resources

A new microarray technology is described for rapid, inexpensive, multiplex diagnostics assays. Referred to as in-plane parallel scanning (IPPS), this technology replaces expensive laser scanning with a grid of 100-mu m-wide waveguides embedded in the chip's substrate, enabling real-time quantification of molecular complex formation on the chip's surface. Compared to conventional microarray technology, IPPS has advantages of shorter assay time and lower instrument cost and complexity so that the platform can potentially be used in point-of-care (POC) settings. Two different chip formats are described: a low-density microarray with 10 sensing wells (IPPS-10) and a medium-density one with 100 sensing wells (IPPS-100). Performance was evaluated in two different proof-of-principle immunoassays: interleukin-1 beta (IL-1 beta) and Clostridium difficile toxin A. The two assays gave similar limits of detection of 0.67 and 0.94 pM, respectively. A saturation kinetics model described the sensor response with apparent dissociation constants of 511 pM for IL-1 beta and 6.4.7 nM for C. diflicile toxin A toxoid. The multiplexing capabilities of the IPPS technology were also demonstrated in a multiplex assay for both analytes on the same IPPS-10 chip. Based on these results, the IPPS technology holds promise for translating diagnostic microarrays into near-patient environments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available